Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001937939 | SCV002183809 | uncertain significance | not provided | 2021-09-24 | criteria provided, single submitter | clinical testing | This sequence change replaces serine with asparagine at codon 510 of the GLIS3 protein (p.Ser510Asn). The serine residue is highly conserved and there is a small physicochemical difference between serine and asparagine. This variant is present in population databases (rs199817194, ExAC 0.03%). This variant has not been reported in the literature in individuals affected with GLIS3-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Fulgent Genetics, |
RCV002503567 | SCV002814063 | uncertain significance | Neonatal diabetes mellitus with congenital hypothyroidism | 2021-07-03 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001937939 | SCV005196286 | uncertain significance | not provided | criteria provided, single submitter | not provided |